This vial combines two synthetic peptides. Modified GRF (1-29) is a 29 amino acid analogue of the first part of growth-hormone-releasing hormone, with four amino acids substituted for stability. It is often sold as "CJC-1295 no DAC"; the name CJC-1295 on its own normally refers to a different, longer-acting version.
Ipamorelin is a five amino acid peptide developed at Novo Nordisk in the 1990s that acts on the ghrelin receptor (GHSR-1a). Both have mainly been studied in animal models.
Technical details
| Component | Amount | Formula | Molecular weight | CAS |
|---|---|---|---|---|
| Modified GRF (1-29) | 5 mg | C152H252N44O42 | 3367.9 g/mol | |
| Ipamorelin | 5 mg | C38H49N9O5 | 711.9 g/mol | 170851-70-4 |
Research to date: Mostly animal studies; limited human data.
Lab certificate
A third-party certificate of analysis for the current batch will be posted on this page once testing is complete.
Storage
Store the sealed vial in a freezer at around -20 °C, away from light and moisture.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic purposes.
